Osteoporosis Trial, Recruiting NCT06867952 Sponsor: S.LAB (SOLOWAYS) Condition: Osteoporosis
Back to Osteoporosis

Osteoporosis Trial, Recruiting

NCT06867952
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 40 and 75 years old who have been diagnosed with low bone density or bone loss (called osteopenia or osteoporosis), confirmed by a bone scan called a DXA scan, with a T-score of -1.0 or lower
  • People with stable eating habits who are willing to keep their current exercise routine the same for the whole study
  • People who are willing to have a genetic test to check for a specific gene variation related to vitamin D (called the VDR variant)
  • People who carry two copies of a specific "unfavorable" version of the VDR gene (for one group in the trial)
  • People who do not carry any "unfavorable" version of the VDR gene (for the other group in the trial)

Who may not be able to join:

  • People who are currently using, or have used in the last 3 months, certain bone medications such as high-dose bisphosphonates, teriparatide, or selective estrogen receptor modulators (SERMs)
  • People with a known allergy or sensitivity to vitamin K or vitamin D supplements
  • People with serious kidney or liver problems, uncontrolled overactive thyroid, or other significant health conditions that could affect how the body processes bone
  • People who are pregnant or breastfeeding
  • People who are unable or unwilling to give their consent to participate, or who cannot follow the study procedures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +79628316017

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
S.LAB (SOLOWAYS)
Registry
ClinicalTrials.gov
Start date
3 May 2024
Est. completion
28 February 2026

Where this trial is recruiting

🇷🇺 Russia

Primary endpoints

Change in Bone Mineral Density (BMD)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov